Drug-drug Interaction Study of XZP-3621 Tablet
Condition:   Healthy Subjects Interventions:   Drug: XZP-3621 tablet and itraconazole oral liquid (for Arm1);   Drug: XZP-3621 tablet and Rifampicin capsules (For Arm 2);   Drug: XZP-3621 tablet and esomeprazole tablet (For Arm3) Sponsor:   Xuanzhu Biopharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials